Variables | All patients | Afatinib 30 mg daily | Afatinib 40 mg daily | P value |
---|---|---|---|---|
Initial response to afatinib treatment -n (%) | 0.1486 | |||
Complete response | 1 (2%) | 1 (3%) | 0 (0%) | |
Partial response | 39 (81%) | 21 (72%) | 18 (95%) | |
Stable disease | 8 (17%) | 7 (24%) | 1 (5%) | |
Disease control rate with afatinib treatment (%) | 48 (100%) | 29 (100%) | 19 (100%) | 0.1486 |
Response rate with afatinib treatment (%) | 40 (83%) | 22 (76%) | 18 (95%) | 0.0862 |